|
KCTD9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.54790000000449E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.150300E-04 |
| Normal-vs-Stage2 |
8.922100E-03 |
| Normal-vs-Stage3 |
3.573500E-04 |
| Normal-vs-Stage4 |
1.94493999999823E-05 |
| Stage1-vs-Stage2 |
7.775600E-01 |
| Stage1-vs-Stage3 |
4.296600E-01 |
| Stage1-vs-Stage4 |
8.728100E-02 |
| Stage2-vs-Stage3 |
7.885600E-01 |
| Stage2-vs-Stage4 |
2.567200E-01 |
| Stage3-vs-Stage4 |
3.186400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.56910000000244E-05 |
| Normal-vs-AfricanAmerican |
1.635560E-01 |
| Normal-vs-Asian |
1.366450E-02 |
| Caucasian-vs-AfricanAmerican |
5.341400E-01 |
| Caucasian-vs-Asian |
9.998200E-01 |
| AfricanAmerican-vs-Asian |
6.653600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.118020E-03 |
| Normal-vs-Female |
1.048330E-04 |
| Male-vs-Female |
9.863200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.296000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.7599999999971E-05 |
| Normal-vs-Age(61-80Yrs) |
5.356300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.870800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.193700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.416800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.584800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.693380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.972000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.474400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.680800E-01 |
| Classical-VS-Follicular |
6.167400E-01 |
| Classical-VS-Other |
7.784800E-01 |
| Classical-VS-Normal |
2.359500E-04 |
| Tall-VS-Follicular |
4.147600E-01 |
| Tall-VS-Other |
5.695000E-01 |
| Tall-VS-Normal |
1.740660E-03 |
| Follicular-VS-Other |
9.223600E-01 |
| Follicular-VS-Normal |
1.133560E-02 |
| Other-VS-Normal |
2.474400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.00590000001932E-06 |
| Normal-vs-N1 |
3.812000E-04 |
| N0-vs-N1 |
7.506600E-01 |
|
|
